Arnold B. Rabson
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arnold B. Rabson.
Cell | 1990
Ben Berkhout; Anne Gatignol; Arnold B. Rabson; Kuan-Teh Jeang
Replication of HIV-1 requires Tat, which stimulates gene expression through a target sequence, TAR. It is known that TAR is a Tat-responsive target. Since Tat increases transcriptional initiations from the HIV-1 LTR promoter, it is unclear mechanistically how Tat utilizes an RNA target. Here we show that TAR RNA is only one component of the Tat-responsive target. Efficient Tat trans-activation was observed only when TAR was present in conjunction with the HIV-1 LTR NF-kappa B/SP1 DNA sequences. TAR RNA outside of this context produced a suboptimal Tat response. We propose that TAR RNA serves an attachment function directing Tat to the LTR. A Tat protein engineered to interact with LTR DNA could trans-activate through a TAR-independent mechanism. This suggests that Tat also has a DNA target.
Experimental Cell Research | 1991
Wolfgang Holter; Arnold B. Rabson; Christopher D. Corsico; Bruce H. Howard
Experimental gene transfer and viral infections can result in the accumulation of unintegrated DNA in target cells. The effects of such accumulation on target cell metabolism have not been directly studied. The experiments reported in this paper show that transfection of cloned retroviral long-terminal-repeat (LTR) DNA, or of a variety of eukaryotic promoters, into proliferating HeLa cells results in rapid, sequence-specific, and dose-dependent cell death. Plasmids containing the Rous sarcoma virus LTR or the human immunodeficiency virus LTR cloned in pUC-related plasmids are 5 to 10 times more toxic than pUC19. The demonstrated sensitivity of eukaryotic cells to exogenously introduced DNA has important implications for the interpretation of gene transfer experiments and may be relevant to the pathogenic mechanisms in the course of retroviral infections such as AIDS.
Gene Analysis Techniques | 1988
Arnold B. Rabson; Scott Koenig; Daryl F. Daugherty; Howard E. Gendelman
Molecular studies of the pathogenesis of human immunodeficiency virus (HIV) infections have proceeded rapidly following the molecular cloning and nucleotide sequence analysis of the HIV genome. Correlation of biochemical and functional studies of HIV-infected cells with the HIV nucleotide sequence has allowed the identification and preliminary functional characterization of many HIV proteins. These include structural proteins (gag), viral enzymes (pol), and viral regulatory proteins (tat, art). Cloned HIV DNA segments have been utilized as probes for in situ nucleic acid hybridization to study the distribution of HIV-infected cells in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC) patients. These studies have demonstrated the infection of macrophages as an important component of HIV-induced neurologic disease. Only very low numbers of HIV-infected lymphocytes can be identified in the peripheral blood of infected individuals. Thus, the mechanism of CD4 cell depletion in the pathogenesis of AIDS remain obscure.
Journal of The American Academy of Dermatology | 1990
Arnold B. Rabson
Infection by the human immunodeficiency virus (HIV) may result in a spectrum of disease ranging from asymptomatic seropositivity to the development of profound immunodeficiency. Features of the HIV life cycle may explain aspects of the pathogenesis of HIV-induced disease. The tropism of HIV for CD4+ cells of both lymphocytic and monocytic origin is of considerable importance in bringing about immune deficiency. The variability of the HIV envelope limits the ability of host-immune response to control the infection effectively. Finally, the ability of HIV to persist is latently integrated DNA in infected cells that can be reactivated by cellular signals responsible for the control of normal immune cell activation links HIV replication to normal host cell functions. This can help explain the chronic but progressive nature of the infection.
Cancer Investigation | 1989
Ursula Flatow; Arnold B. Rabson; Patricia Horan Hand; Mark C. Willingham; Alan S. Rabson
We have adapted T24P, a tumorigenic subline of the T24 human bladder cancer cell line, to grow in 5 mM butyrate. In the presence of butyrate, the adapted cells (T24P/B) grow more slowly than the unadapted cells (T24P/C), have a lower saturation density, increased serum requirement for growth, loss of ability to form colonies when plated at low cell density, and decreased ouabain sensitivity. Morphologically, T24P/B cells in butyrate are large and flattened with increased cytoplasm. When T24P/B cells are grown without butyrate, the morphological changes, growth rate, plating efficiency, and ouabain sensitivity return to those of T24P/C. While the saturation density increases, it does not return to levels of T24P/C, and the size of colonies never reaches that of the T24P/C colonies. Both T24P/C and T24P/B are tumorigenic in nude mice, however, the T24P/B tumors differ grossly and microscopically from those produced by T24P/C in that they contain large cystic structures filled with clear fluid and lined by transitional cell epithelium with flattened surface layers. Although the transformed phenotype and tumorigenicity of T24P are modified by adaptation to growth in butyrate, no significant changes in ras oncogene RNA or protein expression were identified.
Proceedings of the National Academy of Sciences of the United States of America | 1989
E. J. Duh; Wendy Maury; Thomas M. Folks; Anthony S. Fauci; Arnold B. Rabson
Journal of Virology | 1985
R Repaske; Paul E. Steele; R R O'Neill; Arnold B. Rabson; Malcolm A. Martin
Journal of Virology | 1987
Jeffrey M. Ostrove; John M. Leonard; Karen E. Weck; Arnold B. Rabson; Howard E. Gendelman
The Journal of Infectious Diseases | 1989
Wendy Maury; Barbara J. Potts; Arnold B. Rabson
Cell | 1985
Arnold B. Rabson; Malcolm A. Martin